Diabetes

Editor's Choice

Making good decisions requires that physicians have reliable and practical data. Comparative effectiveness reviews and objective findings on different medical interventions and strategies, as provided by the Agency for Healthcare Research and Quality in its Effective Health Care Program, can help physicians make the most informed choices among treatment options.

LATEST ARTICLES

New integrated therapies for wound healing on the horizon

An integrated, simultaneous therapy using new treatment options and comprehensive care of the patient's underlying medical issues are leading to great advances in wound healing, according to Harold Brem, M.D., F.A.C.S., chief of the division of wound healing and regenerative medicine, Winthrop University Hospital, Mineola, N.Y.

Focus on 2011: A year of novel pharmacologic agents in review

Throughout 2011, Formulary's "Focus on" articles have examined 10 newly approved or investigational drugs of interest to pharmacy and therapeutics (P&T) committee members. Because many readers have said they frequently refer to this column when making formulary decisions for hospitals, health systems, or managed care organizations, the editors have compiled this review of these agents, along with updates on the regulatory status of each.

Biosynthetic skin substitutes provide rapid healing in stubborn wounds

Skin substitutes offer a number of advantages as wound dressings for persistent wounds in the elderly, according to Tania J. Phillips, M.D., professor of dermatology, Boston University School of Medicine. A primary advantage is that they are not invasive, she says.

Effective Health Care Clinician Guides

Alimera receives CRL from FDA for intravitreal insert

FDA has issued a complete response letter to the New Drug Application for the extended-release intravitreal insert (Iluvien, Alimira Sciences) for the treatment of diabetic macular edema associated with diabetic retinopathy.